These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33617695)

  • 1. Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells.
    Avenali M; Cerri S; Ongari G; Ghezzi C; Pacchetti C; Tassorelli C; Valente EM; Blandini F
    Mov Disord; 2021 May; 36(5):1267-1272. PubMed ID: 33617695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review.
    Behl T; Kaur G; Fratila O; Buhas C; Judea-Pusta CT; Negrut N; Bustea C; Bungau S
    Transl Neurodegener; 2021 Jan; 10(1):4. PubMed ID: 33446243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls.
    den Heijer JM; Cullen VC; Pereira DR; Yavuz Y; de Kam ML; Grievink HW; Moerland M; Leymarie N; Khatri K; Sollomoni I; Spitalny L; Dungeon L; Hilt DC; Justman C; Lansbury P; Groeneveld GJ
    Mov Disord; 2023 May; 38(5):783-795. PubMed ID: 36916660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 1B Trial in GBA1-Associated Parkinson's Disease of BIA-28-6156, a Glucocerebrosidase Activator.
    den Heijer JM; Kruithof AC; Moerland M; Walker M; Dudgeon L; Justman C; Solomini I; Splitalny L; Leymarie N; Khatri K; Cullen VC; Hilt DC; Groeneveld GJ; Lansbury P
    Mov Disord; 2023 Jul; 38(7):1197-1208. PubMed ID: 37195859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma Exosomes in Inherited Forms of Parkinson's Disease].
    Kulabukhova DG; Garaeva LA; Emelyanov AK; Senkevich KA; Gracheva EV; Miliukhina IV; Varfolomeeva EY; Timofeeva AA; Schwartsman AL; Shtam TA; Pchelina SN
    Mol Biol (Mosk); 2021; 55(2):338-345. PubMed ID: 33871446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of β-glucocerebrosidase increases α-synuclein secretion and exosome release in mouse models of Parkinson's disease.
    Papadopoulos VE; Nikolopoulou G; Antoniadou I; Karachaliou A; Arianoglou G; Emmanouilidou E; Sardi SP; Stefanis L; Vekrellis K
    Hum Mol Genet; 2018 May; 27(10):1696-1710. PubMed ID: 29547959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fiber-Specific White Matter Alterations in Parkinson's Disease Patients with GBA Gene Mutations.
    Andica C; Kamagata K; Uchida W; Saito Y; Takabayashi K; Hagiwara A; Takeshige-Amano H; Hatano T; Hattori N; Aoki S
    Mov Disord; 2023 Nov; 38(11):2019-2030. PubMed ID: 37608502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.
    Pchelina S; Emelyanov A; Baydakova G; Andoskin P; Senkevich K; Nikolaev M; Miliukhina I; Yakimovskii A; Timofeeva A; Fedotova E; Abramycheva N; Usenko T; Kulabukhova D; Lavrinova A; Kopytova A; Garaeva L; Nuzhnyi E; Illarioshkin S; Zakharova E
    Neurosci Lett; 2017 Jan; 636():70-76. PubMed ID: 27780739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.
    Omer N; Giladi N; Gurevich T; Bar-Shira A; Gana-Weisz M; Glinka T; Goldstein O; Kestenbaum M; Cedarbaum JM; Mabrouk OS; Fraser KB; Shirvan JC; Orr-Urtreger A; Mirelman A; Thaler A
    Mov Disord; 2022 Jan; 37(1):190-195. PubMed ID: 34550621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [GBA mutations and Parkinson's disease].
    Wang DX; Xie JX; Song N
    Sheng Li Xue Bao; 2018 Jun; 70(3):294-300. PubMed ID: 29926071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome.
    Ruz C; Barrero FJ; Pelegrina J; Bandrés-Ciga S; Vives F; Duran R
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease.
    Taguchi YV; Liu J; Ruan J; Pacheco J; Zhang X; Abbasi J; Keutzer J; Mistry PK; Chandra SS
    J Neurosci; 2017 Oct; 37(40):9617-9631. PubMed ID: 28847804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation.
    Galvagnion C; Marlet FR; Cerri S; Schapira AHV; Blandini F; Di Monte DA
    Brain; 2022 Apr; 145(3):1038-1051. PubMed ID: 35362022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson's Disease.
    Cerri S; Ghezzi C; Ongari G; Croce S; Avenali M; Zangaglia R; Di Monte DA; Valente EM; Blandini F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672321
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Smith L; Schapira AHV
    Cells; 2022 Apr; 11(8):. PubMed ID: 35455941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset.
    Schierding W; Farrow S; Fadason T; Graham OEE; Pitcher TL; Qubisi S; Davidson AJ; Perry JK; Anderson TJ; Kennedy MA; Cooper A; O'Sullivan JM
    Mov Disord; 2020 Aug; 35(8):1346-1356. PubMed ID: 32557794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intronic Haplotypes in the GBA Gene Do Not Predict Age at Diagnosis of Parkinson's Disease.
    Toffoli M; Higgins A; Lee C; Koletsi S; Chen X; Eberle M; Sedlazeck FJ; Mullin S; Proukakis C; Schapira AHV
    Mov Disord; 2021 Jun; 36(6):1456-1460. PubMed ID: 34008887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.
    Gegg ME; Burke D; Heales SJ; Cooper JM; Hardy J; Wood NW; Schapira AH
    Ann Neurol; 2012 Sep; 72(3):455-63. PubMed ID: 23034917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
    Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
    J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease.
    Galper J; Balwani M; Fahn S; Waters C; Krohn L; Gan-Or Z; Dzamko N; Alcalay RN
    Mov Disord; 2021 Jun; 36(6):1451-1455. PubMed ID: 33570220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.